Accessible to Innovation
DNA Script is committed to accelerating the innovation occurring in laboratories across all areas of life science around the world. With our global team of scientists, engineers, and business leaders, we are excited to expand access to our DNA synthesis technologies, products, and expertise to collaboratively enhance workflows, support global initiatives, and advance research programs.
IARPA, Molecular Encoding Consortium: Broad Institute, Harvard University, and DNA Script
DNA Script is enabling our partners to explore the combined use of enzymatic synthesis of DNA and next-generation sequencing to enable accurate and low-cost decoding—an important step to transitioning from digital to biology-based data storage.
French Defense Innovation Agency, French Armament General Directorate
By enabling our partners to leverage Enzymatic DNA Synthesis to quickly generate high-fidelity customized oligos, DNA Script is helping to improve the ability to rapidly iterate and optimize qPCR assays in response to emerging biothreats.
DARPA NOW: GE Research
As a part of the DARPA Nucleic Acids On-Demand Worldwide (NOW) Initiative, DNA Script is collaborating on the development of a mobile medical manufacturing platform by helping GE Research harness Enzymatic DNA Synthesis to rapidly produce thousands of ready-to-use vaccine doses.
DARPA NOW: Moderna
DNA Script has been selected by Moderna, Inc. to partner in their development efforts with the DARPA NOW Initiative. Together we are leveraging Enzymatic DNA Synthesis to generate high-fidelity nucleic acids to power Moderna’s existing manufacturing technology as they work toward rapid-response production of mRNA vaccines and therapeutics.
How can we help you?
We welcome opportunities to partner with innovative leaders committed to serve and advance science and healthcare. Whether it’s to support grant applications or on-going projects, our team is ready to help.